Estradiol receptor profile and estrogen responsiveness in laryngeal cancer and clinical outcomes

Steroids ◽  
2019 ◽  
Vol 142 ◽  
pp. 34-42 ◽  
Author(s):  
Nofrat Schwartz ◽  
Anjali Verma ◽  
Chandana Muktipaty ◽  
Caroline Bivens ◽  
Zvi Schwartz ◽  
...  
Head & Neck ◽  
2016 ◽  
Vol 38 (S1) ◽  
pp. E2035-E2040 ◽  
Author(s):  
Salil Vengalil ◽  
Meredith E. Giuliani ◽  
Shao Hui Huang ◽  
Andrea McNiven ◽  
Yuyao Song ◽  
...  

Author(s):  
Amarkumar Dhirajlal Rajgor ◽  
Shreena Patel ◽  
David McCulloch ◽  
Boguslaw Obara ◽  
Jaume Bacardit ◽  
...  

Objectives: Radiomics is the conversion of medical images into quantitative high-dimensional data. Laryngeal cancer, one of the most common head and neck cancers, has risen globally by 58.7%. CT, MRI and PET are acquired during the diagnostic process providing potential data for radiomic analysis and correlation with outcomes. This review aims to examine the applications of this technique to laryngeal cancer and the future considerations for translation into clinical practice. Methods: A comprehensive systematic review-informed search of the MEDLINE and EMBASE databases was undertaken. Keywords “laryngeal cancer” OR “larynx“ OR “larynx cancer” OR “head and neck cancer” were combined with “radiomic” OR “signature” OR “machine learning” OR “artificial intelligence”. Additional articles were obtained from bibliographies using the “snowball method”. Results: The included studies (n = 15) demonstrated that radiomic features are significantly associated with various clinical outcomes (including stage, overall survival, treatment response, progression-free survival) and that predictive models incorporating radiomic features are superior to those that do not. Two studies demonstrated radiomics could improve laryngeal cancer staging whilst 12 studies affirmed its predictive capability for clinical outcomes. Conclusions: Radiomics has potential for improving multiple aspects of laryngeal cancer care; however, the heterogeneous cohorts and lack of data on laryngeal cancer exclusively inhibits firm conclusions. Large prospective well-designed studies in laryngeal cancer are required to progress this field. Furthermore, to implement radiomics into clinical practice, a unified research effort is required to standardise radiomics practice. Advances in knowledge: This review has highlighted the value of radiomics in enhancing laryngeal cancer care (including staging, prognosis and predicting treatment response).


2013 ◽  
Vol 137 (0) ◽  
pp. 100-101
Author(s):  
Masashi Ogami ◽  
Shigeki Tsuchihashi ◽  
Satomi Moriyama ◽  
Michiaki Yokoyama

2013 ◽  
Vol 106 (6) ◽  
pp. 531-536
Author(s):  
Masashi Ogami ◽  
Shigeki Tsuchihashi ◽  
Satomi Moriyama ◽  
Michiaki Yokoyama

2014 ◽  
Vol 111 ◽  
pp. S24
Author(s):  
S. Pedretti ◽  
L. Costa ◽  
F. Foscarini ◽  
S. Ciccarelli ◽  
G. Pascale ◽  
...  

BMC Cancer ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Akimichi Minesaki ◽  
Keita Kai ◽  
Yuichiro Kuratomi ◽  
Shinichi Aishima

Abstract Background The prognosis of advanced laryngeal cancer is unfavorable despite advances in multidisciplinary therapy. Dendritic cells (DCs) play a central role in antitumor immunity. Tumor-infiltrating CD1a+ DCs have been reported to be associated with clinical outcomes in carcinomas of various organs, but the clinical impact of CD1a+ DCs in laryngeal cancer remains to be unequivocally established. Methods We retrospectively analyzed the cases of 57 patients with Stage III or IV laryngeal cancer who underwent a total laryngectomy. Immunohistochemistry detection of CD1a, S100 and CD8 was performed on representative resected specimens. CD1a+ DCs, S100+ DCs and CD8+ cytotoxic T-lymphocytes (CTLs) were evaluated, and the cases divided into high and low groups according to the cut-off of the median values for each of these 3 parameters. Results Compared to the CD1a-low group, the CD1a-high group had more advanced cases and showed significantly worse disease-specific survival (DSS) (P = 0.008) and overall survival (OS) (P = 0.032). The analyses of S100 DCs and CD8+ CTLs revealed no significant impact on clinical outcomes. However, multivariate analysis revealed that infiltration of CD1a+ DCs was an independent unfavorable prognostic factor for both DSS (P = 0.009) and OS (P = 0.013). Conclusions Our results demonstrated that the infiltration of CD1a+ DCs was associated with unfavorable clinical outcomes in patients with advanced laryngeal cancer who underwent a total laryngectomy as the initial treatment.


2020 ◽  
Vol 106 (5) ◽  
pp. 1140-1141
Author(s):  
A. Burr ◽  
P.M. Harari ◽  
A. Haasl ◽  
R.J. Kimple ◽  
G.K. Hartig ◽  
...  

2019 ◽  
Vol 29 (1) ◽  
pp. 47-51
Author(s):  
Yoshiki Watanabe ◽  
Shinzo Tanaka ◽  
Yasuyuki Hiratsuka ◽  
Takao Yoshida ◽  
Junko Kusano ◽  
...  

2020 ◽  
Author(s):  
Akimichi Minesaki ◽  
Keita Kai ◽  
Yuichiro Kuratomi ◽  
Shinichi Aishima

Abstract Background: The prognosis of advanced laryngeal cancer is unfavorable despite the progress of multidisciplinary therapy. Dendritic cells (DCs) play a central role in antitumor immunity. Tumor-infiltrating CD1a+ DCs have been reported to be associated with clinical outcomes in carcinomas of various organs, but the clinical impact of CD1a+ DCs in laryngeal cancer has not been clear.Patients and Methods: We retrospectively analyzed the cases of 57 patients with Stage Ⅲ or Ⅳ laryngeal cancer who underwent a total laryngectomy. Immunohistochemistry for CD1a, S100, and CD8 was performed using representative resected specimens. CD1a+ DCs, S100+ DCs, and CD8+ cytotoxic T-lymphocytes (CTLs) were evaluated, and we divided the cases into high and low groups by the cut-off of the median value for each of these three parameters.Results: Compared to the CD1a-low group, the CD1a-high group had more advanced cases and showed significantly worse disease-specific survival (DSS) (p=0.0082) and overall survival (OS) (p=0.0324). The analyses of S100 DCs and CD8+ CTLs revealed no significant impact on clinical outcomes. Multivariate analyses indicated that the infiltration of CD1a+ DCs ​​​is an independent unfavorable prognostic factor in both DSS (p=0.0093) and OS (p=0.0132).Conclusions: Our results demonstrated that the infiltration of CD1a+ DCs was associated with unfavorable clinical outcomes. It is not yet known why the presence of CD1a+ DCs lead to an unfavorable clinical outcome in laryngeal cancer. Further studies are necessary to validate our results and clarify the function(s) of tumor-infiltrating CD1a+ DCs.


Sign in / Sign up

Export Citation Format

Share Document